Legacy Wealth Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
MSV
AP
CA
SC
FFBTD
FFA
GI
VWM
SCA
Legacy Wealth Asset Management's GILD Position: Q3 2026 in Review
Legacy Wealth Asset Management reduced its Gilead Sciences (GILD) stake by 1.1% in Q3 2026, selling an estimated $11.1K and leaving 7,343 shares worth $1.09M. The position accounts for 0.24% of the portfolio, ranked #121.
Legacy Wealth Asset Management first reported a position in GILD in Q4 2020 and has held it in 24 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Legacy Wealth Asset Management held 7,343 shares of Gilead Sciences worth $1.09M as of Q3 2026.
- Legacy Wealth Asset Management sold 79 Gilead Sciences shares in Q3 2026, an estimated $11.1K.
- Gilead Sciences made up 0.24% of Legacy Wealth Asset Management's portfolio in Q3 2026, its #121 holding.
- Legacy Wealth Asset Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 24 quarters since.
- 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Legacy Wealth Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.